StimCell reports positive mitochondrial function study results

VANCOUVER, BC - StimCell Energetics Inc. (OTCQB:STME) unveiled initial findings from a joint study with St. Boniface Hospital Albrechtsen Research Centre and the University of Manitoba. The research examined the effects of the company's eBalance microcurrent technology on mitochondrial function in rat sensory neurons. Utilizing a service agreement established in December 2025, the study analyzed oxygen consumption rate and extracellular acidification rate to gauge cellular energy production.

Key findings revealed a 49% boost in basal respiration, a 119% surge in maximal respiration, and a 174% enhancement in spare respiratory capacity. Moreover, extracellular acidification rate during peak stimulation exhibited an approximate 85-90% increase, signifying heightened glycolytic activity. Conducted in cultured healthy adult rat sensory neurons using Seahorse-based bioenergetic assays at the laboratory of Professor Paul Fernyhough, these preliminary results demonstrated a clear, statistically significant impact of eBalance stimulation on multiple aspects of mitochondrial function in healthy adult rat sensory neurons.

Professor Fernyhough highlighted that sensory neurons sourced from adult rat dorsal root ganglia serve as a reliable model mirroring human sensory neurons in both morphology and physiology. David Jeffs, CEO of StimCell Energetics, emphasized these results as a significant milestone for the company's platform. The company acknowledged these findings as preliminary, originating from initial experimental rounds.

Ongoing analyses, encompassing longer-term stimulation studies and complementary molecular assays, are underway. Discussions are in progress to extend the research program, with a comprehensive report anticipated upon the completion of the full experimental program. StimCell Energetics is dedicated to the development and commercialization of products designed to enhance cellular function and promote wellness.